India clears Mylan's plant buy, to vet Perrigo, Hospira plans next week
This article was originally published in Scrip
Executive Summary
India has cleared foreign direct investment (FDI) plans worth Rs8.02 billion ($146 million) across various industry sectors, including Mylan's acquisition of an oncology manufacturing facility for Rs1.73 billion. Nine proposals, including those of Perrigo API India and Hospira, were deferred however.